Form 144 ASP Isotopes Inc. For: 17 April
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ASP Isotopes Inc (ASPI)
The ASP Isotopes share price today is 5.350 %REPORT_CURRENCY%, view NASDAQ ASPI stock exchange data. Track the latest ASP Isotopes share price with real-time updates on ASPI stock performance including market cap, day range, 52-week range and dividend yield. Access ASPI charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.195
5.630
52 wk Range
3.920
14.490
ASPI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.1955.630
52 wk Range
3.92014.490
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ASPI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
13.000
Upside
+142.99%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Ainscow, ASP isotopes COO, sells $112k in ASPI stock
- Investing.com
- Form 144 ASP Isotopes Inc. For: 16 April
- Investing.com
- Form 144 ASP Isotopes For: 15 April
- Investing.com
- Form 144 ASP Isotopes Inc. For: 17 April
- Investing.com
- Form 144 ASP Isotopes Inc. For: 16 April
- Investing.com
- Form 144 ASP Isotopes For: 15 April
- Investing.com
- Form 144 ASP Isotopes Inc. For: 13 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.
ASP Isotopes Inc Earnings Call Summary for Q4/2025
- ASP Isotopes reported 480% revenue growth to $23.8M in 2025, driven by transition from infrastructure development to commercial operations.
- Company maintains strong cash position of $333M in reserves after raising over $345M in capital during 2025 to fund expansion initiatives.
- Radiopharmaceutical product revenue reached $5.7M, up 46% YoY; company targets doubling this segment's revenue in 2026 with 63% overall growth forecast.
- Strategic focus on expanding Ytterbium-176 and Carbon-14 production capacity to capture growing nuclear medicine and semiconductor market demand.
- Stock rose 2.46% premarket to $4.59 despite 66% six-month decline; analysts set price targets of $11-$13, indicating significant upside potential.
Last Updated: 13-04-2026, 06:10 pm
Read Full TranscriptCompare ASPI to Peers and Sector
Metrics to compare | ASPI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASPIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.8x | −0.1x | 3.8x | |
PEG Ratio | 0.02 | 0.01 | 0.00 | |
Price/Book | 3.3x | 2.5x | 1.6x | |
Price / LTM Sales | 28.2x | 2.1x | 1.4x | |
Upside (Analyst Target) | 148.1% | 17.0% | 25.3% | |
Fair Value Upside | Unlock | 4.5% | −0.6% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.000
(+142.99% Upside)
Earnings
Latest Release
25-02-2026
EPS / Forecast
-0.79 / -0.02
Revenue / Forecast
16.66M / --
FAQ
What Is the ASP Isotopes (ASPI) Share Price Today?
The ASP Isotopes share price today is 5.350 USD.
What is the current ASP Isotopes (ASPI) share price and day range?
As of 25-04-2026, the ASP Isotopes share price is 5.350 USD, with a previous close of 5.430 USD. The share price has ranged from 5.195 to 5.630 USD today, while the 52-week range spans from 3.920 to 14.490 USD.
What Is the ASP Isotopes Market Cap?
As of today, ASP Isotopes market cap is 673.580M.
What Is the ASP Isotopes (ASPI) Share Price Target?
The average 12-month share price target for ASP Isotopes is 13.000 USD, with a high estimate of 15 USD and a low estimate of 11 USD. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +142.99% Upside potential.
What Is ASP Isotopes's Earnings Per Share (TTM)?
The ASP Isotopes EPS (TTM) is -2.109.
When Is the Next ASP Isotopes Earnings Date?
ASP Isotopes will release its next earnings report on 03-06-2026.
From a Technical Analysis Perspective, Is ASPI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
What Stock Exchange Does ASP Isotopes Trade On?
ASP Isotopes is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for ASP Isotopes?
The stock symbol for ASP Isotopes is "ASPI."
How Many Times Has ASP Isotopes Stock Split?
ASP Isotopes has split 0 times.
How Many Employees Does ASP Isotopes Have?
ASP Isotopes has 271 employees.
What Is the ASPI Premarket Price?
ASPI's last pre-market stock price is 5.597 USD. The pre-market share volume is 93,640.000, and the stock has changed by 0.167 USD, or 3.080%.
What Is the ASPI After Hours Price?
ASPI's last after hours stock price is 5.450 USD, the stock has changed by 0.100 USD, or 1.870%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.